PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23522182-0	2013	Dose-ranging study with the glucokinase activator AZD1656 as monotherapy in Japanese patients with type 2 diabetes mellitus.	AZD1656	50-57	glucokinase	Homo sapiens	28-39	
23522182-1	2013	AIM: To assess the glucose-lowering effects of monotherapy with the glucokinase activator AZD1656 in Japanese patients with type 2 diabetes mellitus.	AZD1656	90-97	glucokinase	Homo sapiens	68-79